Provaris Energy Ltd (ASX:PV1, OTC:GBBLF, FRA:WS90) has completed a $1 million placement to support key 2026 technical ...

The planned Phase 3 trial in approximately 750 postmenopausal women with osteoporosis, with a primary endpoint of total hip ...

The state sued Step Up on Second and other organizations in January 2024 alleging fraud related to the Homekey program.

“As we reported last month, we have achieved over 50% of the current targeted enrollment in the first trial in this Phase 3 program (COVE-2) in the U.S. and have also been enrolling U.S. patients in ...

Matching qualified and interested job seekers with available jobs is at the heart of the work that we do at the Santa Barbara ...

LLVM powers the core development tools, operating systems, and most applications at Apple Computer, where it long ago ...

Approval from Health Canada to expand Serenta Registrational Phase 3 trial in FAP and Update on Serenta Progress. Biodexa Pharmaceuticals PLC (Nasdaq: BDRX) (“Bio ...

St. Louis will host July workshops and a virtual meeting to present draft zoning development standards, share map updates, ...

Revolution Medicines, a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced that it has begun treating patients in RASolute 305, ...

CRANBROOK, BC / ACCESS Newswire / July 3, 2026 / Eagle Plains Resources Ltd. (TSXV:EPL)(OTCQB:EGPLF) ("EPL" or "Eagle ...

MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today provides shareholders a ...